Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
12/20/2006
 
First Published:
2/21/2003
1.
Phase III Randomized Study of Neoadjuvant Releasing Factor Agonist Therapy and Antiandrogen Therapy With or Without Docetaxel And Estramustine in Patients With Locally Advanced Prostate Cancer or With A High Risk of Relapse
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Under 80
Other
FRE-FNCLCC-GETUG-12/0203
EU-20238, NCT00055731
Last Modified:
10/16/2006
 
First Published:
8/6/2006
2.
Phase III Randomized Study of Intermittent Versus Continuous Cyproterone Acetate in Patients With Newly Diagnosed Stage III or IV Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Under 80
Other
SEUG-9901
BARTS-SEUK-9901, MREC-04/5/006, BARTS-P/02/203, EU-20630, NCT00363285
Last Modified:
6/19/2008
 
First Published:
10/21/2006
3.
Phase III Randomized Pilot Study of Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Patients With Localized Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Not specified
Other
ICR-CTSU-CHHIP-2006-10007
ISRCTN97182923, EU-20646, NCT00392535
Last Modified:
5/13/2008
 
First Published:
3/7/2008
4.
Phase III Randomized Study of Active Monitoring Versus Radical Prostatectomy Versus Radical Radiotherapy in Patients With Localized Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Health services research, Treatment
Active
50 to 69
Other
SHEFF-PROTECT
PROTECT, ISRCTN20141297, EU-20802, SHEFF-HTA-96/20/99, NCT00632983
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute